Narwhal Capital Management Novartis Ag Transaction History

Narwhal Capital Management

  • $1.09 Billion
  • Q4 2024

A detailed history of Narwhal Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Narwhal Capital Management holds 53,208 shares of NVS stock, worth $5.95 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
53,208
Previous 53,875 1.24%
Holding current value
$5.95 Million
Previous $6.2 Million 16.45%
% of portfolio
0.47%
Previous 0.57%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$96.78 - $117.18 $64,552 - $78,159
-667 Reduced 1.24%
53,208 $5.18 Million
Q3 2024

Oct 22, 2024
SELL
$106.13 - $120.89 $9,763 - $11,121
-92 Reduced 0.17%
53,875 $6.2 Million
Q2 2024

Aug 05, 2024
BUY
$92.57 - $107.37 $44,433 - $51,537
480 Added 0.9%
53,967 $5.75 Million
Q1 2024

Apr 26, 2024
SELL
$95.27 - $108.47 $9,145 - $10,413
-96 Reduced 0.18%
53,487 $5.17 Million
Q4 2023

Jan 24, 2024
SELL
$92.27 - $101.54 $45,489 - $50,059
-493 Reduced 0.91%
53,583 $5.41 Million
Q3 2023

Oct 27, 2023
SELL
$94.73 - $105.13 $77,583 - $86,101
-819 Reduced 1.49%
54,076 $5.51 Million
Q2 2023

Aug 02, 2023
SELL
$92.52 - $104.91 $25,720 - $29,164
-278 Reduced 0.5%
54,895 $5.54 Million
Q1 2023

May 01, 2023
SELL
$80.03 - $92.81 $8,483 - $9,837
-106 Reduced 0.19%
55,173 $5.08 Million
Q4 2022

Jan 30, 2023
SELL
$75.55 - $92.52 $6,799 - $8,326
-90 Reduced 0.16%
55,279 $5.01 Million
Q2 2022

Aug 01, 2022
BUY
$80.52 - $93.75 $76,977 - $89,625
956 Added 1.76%
55,369 $4.68 Million
Q1 2022

Apr 26, 2022
SELL
$80.11 - $90.62 $220,863 - $249,839
-2,757 Reduced 4.82%
54,413 $4.78 Million
Q4 2021

Jan 26, 2022
SELL
$79.7 - $88.13 $1.02 Million - $1.13 Million
-12,768 Reduced 18.26%
57,170 $5 Million
Q3 2021

Oct 22, 2021
SELL
$81.78 - $95.14 $1.32 Million - $1.54 Million
-16,159 Reduced 18.77%
69,938 $5.72 Million
Q2 2021

Jul 29, 2021
SELL
$85.24 - $94.15 $1.25 Million - $1.39 Million
-14,712 Reduced 14.59%
86,097 $7.86 Million
Q1 2021

Apr 23, 2021
SELL
$83.5 - $98.47 $356,795 - $420,762
-4,273 Reduced 4.07%
100,809 $8.62 Million
Q4 2020

Feb 02, 2021
BUY
$78.07 - $94.43 $737,683 - $892,269
9,449 Added 9.88%
105,082 $9.92 Million
Q3 2020

Oct 26, 2020
BUY
$82.14 - $91.0 $531,938 - $589,316
6,476 Added 7.26%
95,633 $8.32 Million
Q2 2020

Jul 22, 2020
SELL
$80.93 - $91.1 $6.73 Million - $7.58 Million
-83,160 Closed
0 $0
Q1 2020

Apr 30, 2020
BUY
$70.67 - $99.01 $891,290 - $1.25 Million
12,612 Added 17.88%
83,160 $6.86 Million
Q4 2019

Jan 31, 2020
SELL
$84.35 - $95.37 $4,554 - $5,149
-54 Reduced 0.08%
70,548 $6.68 Million
Q3 2019

Oct 31, 2019
BUY
$85.54 - $94.26 $282,538 - $311,340
3,303 Added 4.91%
70,602 $6.14 Million
Q2 2019

Jul 30, 2019
SELL
$75.4 - $92.8 $323,315 - $397,926
-4,288 Reduced 5.99%
67,299 $6.15 Million
Q1 2019

Apr 12, 2019
SELL
$75.32 - $86.15 $100,175 - $114,579
-1,330 Reduced 1.82%
71,587 $6.88 Million
Q3 2018

Oct 23, 2018
BUY
$66.94 - $77.43 $391,264 - $452,578
5,845 Added 8.71%
72,917 $6.28 Million
Q2 2018

Jul 19, 2018
BUY
$64.91 - $73.36 $355,382 - $401,646
5,475 Added 8.89%
67,072 $5.07 Million
Q1 2018

Apr 17, 2018
BUY
$70.39 - $84.15 $248,969 - $297,638
3,537 Added 6.09%
61,597 $4.98 Million
Q4 2017

Jan 23, 2018
BUY
$72.33 - $77.64 $354,417 - $380,436
4,900 Added 9.22%
58,060 $4.88 Million
Q3 2017

Oct 17, 2017
BUY
$74.14 - $77.27 $3.94 Million - $4.11 Million
53,160
53,160 $4.56 Million

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Narwhal Capital Management Portfolio

Follow Narwhal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email